Risk factors and management of hypotension and nausea during 5-aminolevulinic acid-assisted transurethral resection of bladder tumors under spinal anesthesia

Le résumé fourni par la source

OBJECTIVE: This study aimed to evaluate intraoperative adverse events in patients undergoing photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) using oral 5-aminolevulinic acid (5-ALA) (ALA-PDD-TURBT) under spinal anesthesia. METHODS: This single-center retrospective study included 109 patients who underwent ALA-PDD-TURBT under spinal anesthesia between January 2019 and April 2023. Hypotension was defined as a systolic blood pressure ≤ 80 mmHg. We evaluated the incidence of any adverse events and investigated the risk factors for hypotension, nausea, and vomiting. RESULTS: Hypotension was observed in 64 patients (58.7 %), while nausea and vomiting were observed in 29 patients (26.6 %). No adverse events of Clavien-Dindo grade ≥ 3 were observed. No significant association was found between hypotension and various patient-related factors, including age, sex, smoking history, comorbidities, presence of hypertension, use of antihypertensive agents, continuation of antihypertensive medication on the day of surgery, and administration of α-blockers for benign prostatic hyperplasia on examination. Regarding nausea and vomiting, the use of phenylephrine was identified as a significant risk factor (odds ratio, 10.2; 95 % confidence interval, 1.92-53.90; P < 0.01). CONCLUSIONS: Our findings suggest that ALA-PDD-TURBT is a safe procedure with a low risk of severe complications. Although hypotension, nausea, and vomiting were relatively common, they were generally manageable with pharmacological interventions. No strong predictive risk factors for hypotension were identified; however, the use of phenylephrine was associated with an increased risk of nausea and vomiting.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.